Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses-Reference-Cited by-同舟云学术

Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses

Published:2020-12 Issue:12 Volume:28 Page:2540-2552
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Huff Amanda L.,Evgin Laura,Thompson Jill,Kottke Tim,Driscoll Christopher B.,Tonne Jason,Wongthida Phonphimon,Schuelke Matthew,Shim Kevin G.,Mer Georges,Ramirez-Alvarado Marina,Vile Richard

Funder

Cancer Research UK

University of Minnesota

National Institutes of Health

Mayo Clinic

European Research Council

Mayo Foundation for Medical Education and Research

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference48 articles.

1. Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines;Holay;Front. Immunol.,2017

2. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus;Diaz;Cancer Res.,2007

3. Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors;Kottke;Nat. Med.,2011

4. Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus;Wongthida;Hum. Gene Ther.,2011

5. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus;Bridle;Mol. Ther.,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model;Molecular Therapy - Methods & Clinical Development;2023-03

2. Rational selection of an ideal oncolytic virus to address current limitations in clinical translation;Viral Vectors in Cancer Immunotherapy;2023

3. Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice;Science Translational Medicine;2022-04-13

4. Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis;Scientific Reports;2021-07-27